Taken together, our findings propose a promising approach for therapeutic intervention, suggesting that targeting IL-10RA or IDO expression in tumours-surround stromal cells may unleash the full potential of T cells-mediated tumour eradication, renewing hope in precision immunotherapy against cancer. Here, IDO1 is linked to neoplasm.